Each vial gets opened, used once, and discarded
doi: 10.1136/gutjnl-2020-323617 91 NicolucciA.CharbonnelB.GomesM
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
By targeting receptors in the liver, Retatrutide encourages the body to burn more calories at rest, effectively increasing the basal metabolic rate
These insights, interpreted with a qualified healthcare provider, help frame whether GHK-Cu fits within your broader wellness strategy
The findings come at a moment when scientists are exploring the use of GLP-1 drugs to treat other conditions beyond type 2 diabetes and obesity, such as sleep apnea and addiction